Comorbidities and Clinical Response to Cardiac Resynchronization Therapy: Patient ‐Level Meta‐analysis From Eight Clinical Trials
ConclusionIn a meta-analysis of patient-level data from eight major trials, the totality of evidence suggests that CRT reduces HFH and/or all-cause mortality even when several comorbid diseases are present.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Marat Fudim,
Frederik Dalgaard,
Daniel J. Friedman,
William T. Abraham,
John G. F. Cleland,
Anne B. Curtis,
Michael R. Gold,
Valentina Kutyifa,
Cecilia Linde,
Fatima Ali ‐Ahmed,
Anthony Tang,
Antonio Olivas‐Martinez,
Lurdes Y.T. Inoue,
Sa Tags: Research Article Source Type: research
More News: Atrial Fibrillation | Cardiac Resynchronization Therapy | Cardiology | Clinical Trials | Diabetes | Endocrinology | Heart | Heart Failure | Hypertension